The Application of Traditional Chinese Medicine Injection on Patients with Acute Coronary Syndrome during the Perioperative Period of Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- PMID: 32508947
- PMCID: PMC7254090
- DOI: 10.1155/2020/3834128
The Application of Traditional Chinese Medicine Injection on Patients with Acute Coronary Syndrome during the Perioperative Period of Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Abstract
Introduction: TCMI with the effect of Liqihuoxue and Yiqihuoxue has been applied as complementary therapies during the perioperative period of PCI for patients with ACS, while the recommended time points and plans of TCMI are still short of the support of evidence-based medicine.
Methods: A systematic review and meta-analysis was conducted to evaluate the clinical efficacy and safety of TCMI on patients with ACS during the perioperative period of PCI. RCTs were searched based on standardized searching rules in seven medical databases from the inception up to August 2019. Two reviewers conducted the study selection, data extraction, and quality analysis independently. Data were analysed with the support of software RevMan and Stata.
Results: A total of 68 articles with 6,043 patients were enrolled. The result of meta-analysis showed that the TCMI combined with western medicine was superior to the western medicine alone on clinical efficiency (before the PCI, before and after the PCI, or overall, P < 0.05), the occurrence of MACE (myocardial infarction and stenocardia: before the PCI, before and after the PCI, or overall, P < 0.05; arrhythmia: before and after the PCI, P < 0.05), and the level of inflammatory factors (hs-CRP: before the PCI, before and after the PCI, or overall, P < 0.05; IL-6: after the PCI, P < 0.05). The TCMI with the effect of Liqihuoxue obtained more support compared with Yiqihuoxue based on the result of meta-analysis.
Conclusions: TCMI with the effect of Liqihuoxue or Yiqihuoxue combined with western medicine generally showed the potential advantage on the treatment of ACS during the perioperative period of PCI. However, the optimal time point of intervention and recommended plan based on the effect still needs more clinical evidence. We consider that the research of precise and standardized application of TCMI will be a promising direction for TCM in the future.
Copyright © 2020 Zhaofeng Shi et al.
Conflict of interest statement
All authors declare that there are no conflicts of interest regarding the publication of this paper.
Figures











Similar articles
-
Effect of Danhong injection on prognosis and inflammatory factor expression in patients with acute coronary syndrome during the perioperative period of percutaneous coronary intervention: A systematic review and meta-analysis.Front Cardiovasc Med. 2022 Nov 21;9:1029387. doi: 10.3389/fcvm.2022.1029387. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36479564 Free PMC article.
-
[Meta-analysis of effect of Qishen Yiqi Dripping Pills combined with Western medicine on adverse cardiovascular events and quality of life after percutaneous coronary intervention].Zhongguo Zhong Yao Za Zhi. 2021 Mar;46(6):1498-1510. doi: 10.19540/j.cnki.cjcmm.20200618.501. Zhongguo Zhong Yao Za Zhi. 2021. PMID: 33787149 Chinese.
-
Traditional Chinese medicine injections with Tonifying Qi, equivalent effect of regulating energy metabolism, for acute myocardial infarction: a systematic review and meta-analysis of randomized clinical trials.Front Pharmacol. 2025 Mar 28;16:1511486. doi: 10.3389/fphar.2025.1511486. eCollection 2025. Front Pharmacol. 2025. PMID: 40223935 Free PMC article.
-
Effects of sodium tanshinone IIA sulfonate injection on inflammatory factors and vascular endothelial function in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A systematic review and meta-analysis of randomized clinical trials.Front Pharmacol. 2023 Mar 7;14:1144419. doi: 10.3389/fphar.2023.1144419. eCollection 2023. Front Pharmacol. 2023. PMID: 36959861 Free PMC article.
-
Efficacy of short-term high-dose atorvastatin pretreatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of nine randomized controlled trials.Clin Cardiol. 2013 Dec;36(12):E41-8. doi: 10.1002/clc.22198. Epub 2013 Aug 27. Clin Cardiol. 2013. PMID: 24038054 Free PMC article. Review.
Cited by
-
Exploring the Complementary Role of Traditional Chinese Medicine in Enhancing Percutaneous Coronary Intervention Outcomes: Mechanisms, Benefits, and Future Research Directions.Ther Clin Risk Manag. 2025 Jul 10;21:1069-1083. doi: 10.2147/TCRM.S511630. eCollection 2025. Ther Clin Risk Manag. 2025. PMID: 40666694 Free PMC article.
-
Downregulation of serum miR-30c-5p serves as a biomarker to predict disease onset and short-term prognosis in acute coronary syndrome patients.J Cardiothorac Surg. 2025 Jan 4;20(1):12. doi: 10.1186/s13019-024-03258-w. J Cardiothorac Surg. 2025. PMID: 39755617 Free PMC article.
-
Jia-Wei-Si-Miao-Yong-An decoction modulates intestinal flora and metabolites in acute coronary syndrome model.Front Cardiovasc Med. 2023 Jan 4;9:1038273. doi: 10.3389/fcvm.2022.1038273. eCollection 2022. Front Cardiovasc Med. 2023. PMID: 36684592 Free PMC article.
-
Retrospective study on the value of serum angiopoietin 2 and cystatin C levels in the early diagnosis of acute coronary syndrome.Medicine (Baltimore). 2025 Aug 15;104(33):e43650. doi: 10.1097/MD.0000000000043650. Medicine (Baltimore). 2025. PMID: 40826711 Free PMC article.
-
Combined Therapy with Traditional Chinese Medicine and Antiplatelet Drugs for Ischemic Heart Disease: Mechanism, Efficacy, and Safety.Evid Based Complement Alternat Med. 2021 Oct 27;2021:9956248. doi: 10.1155/2021/9956248. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34745309 Free PMC article. Review.
References
-
- Adam T. Acute coronary syndromes. BMJ. 2015;351:p. h5153. - PubMed
-
- Emergency medicine branch of Chinese medical association. Emergency rapid diagnosis and treatment of guidelines acute coronary syndrome. Chinese Journal of Emergency Medicine. 2016;36(4):207–214.
-
- Liyuan M., Yazhe W., Wen W. Interpretation of the report on cardiovascular diseases in China (2017) Chinese Journal of Cardiovascular Medicine. 2018;23(1):1–20.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous